Sort
53,477 grants matching “addiction”
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024
$805,727Deborah S. Hasin · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2019 · DA
Prevention of Neonatal Abstinence Syndrome
$805,666Gary A Peltz · Stanford University · R01 · FY2015 · HD
in vivo investigation of KOR as a marker of BPD and suicide related endophenotypes
$805,619Margaret Taylor Davis · Yale University · R01 · FY2023 · MH
USD MED: NEURAL MECHANISMS OF ADAPTIVE BEHAVIOR
$805,582Joyce Keifer · University Of South Dakota · P20 · FY2008 · RR
Increasing Peer Support for OUD Recovery during COVID-19 through Digital Health: A National Randomized Controlled Trial
$805,537Francesca Beaudoin · Brown University · R01 · FY2023 · DA
Ecologic Stressors, PTSD, and Drug Use in Detroit
$805,289Allison E Aiello · University Of Michigan At Ann Arbor · R01 · FY2010 · DA
An adoption study of the development of early substance use: the joint roles of genetic influences, prenatal risk, rearing environment, and pubertal maturation
$805,267Jenae M. Neiderhiser · Pennsylvania State University, The · R01 · FY2021 · DA
Digital Therapeutic Development of Virtual Cognitive-Affective Training for Opioid Use Disorder
$805,212Risa B Weisberg · Behavr, Llc · R44 · FY2024 · DA
Testing of a patient-centered e-health implementation model in addiction treatment
$805,033Todd David Molfenter · University Of Wisconsin-Madison · R01 · FY2021 · DA
NorthStar Node of the Clinical Trials Network
$805,020Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2017 · DA
Neuronal connectivity within the mesolimbic system
$804,953Marisela Morales · National Institute On Drug Abuse · ZIA · FY2012 · DA
Modeling Goal-Oriented Versus Habitual Drug-Seeking and Taking In Rodents
$804,953Marisela Morales · National Institute On Drug Abuse · ZIA · FY2012 · DA
Project 2: Low Nicotine Content Cigarettes in Vulnerable Populations: p233-288
$804,829Stephen T Higgins · University Of Vermont & St Agric College · P50 · FY2013 · DA
Molecular Codes for the Establishment of Functionally Segregated Dopaminergic Circuits
$804,750Hisashi Umemori · Boston Children'S Hospital · R01 · FY2022 · MH
Methamphetamine and Cysteinyl Leukotrienes in HIV Persistence
$804,728Marcus Kaul · University Of California Riverside · R01 · FY2025 · DA
A Randomized Controlled Trial of A Digital, Self-Guided, Avatar Assisted- Cognitive Behavioral Therapy Platform to Treat Addiction: Digital RITch®CBT vs. Standard CBT
$804,694Caroline J. Easton · Rochester Institute Of Technology · UG3 · FY2022 · DA
Peer-Delivered Behavioral Activation Intervention to Improve Adherence to MAT Among Low-Income, Minority Individuals With OUD
$804,521Jessica F Magidson · Univ Of Maryland, College Park · R61 · FY2019 · AT
Communicating about Nicotine and Differential Risks of Tobacco Products in Priority Populations
$804,341Lyudmila Popova · Georgia State University · R01 · FY2024 · CA
Cannabinoid Epigenomic and miRNA mechanisms impact HIV/SIV disease progression
$803,737Patricia E Molina · Lsu Health Sciences Center · R01 · FY2011 · DA
Molecular mechanisms of memory maintenance and dysfunction in neural circuits
$803,477Todd C Sacktor · Suny Downstate Medical Center · R01 · FY2018 · MH
Center for Metabolic Research on HIV and Drug Use
$803,125Sherwood L Gorbach · Tufts University Boston · P30 · FY2009 · DA
Prevention of Neonatal Abstinence Syndrome
$803,084Gary A Peltz · Stanford University · R01 · FY2014 · HD
NOVEL PHARMACOTHERAPY FOR TREATMENT OF COCAINE ADDICTION
$803,012Research Triangle Institute · U19 · FY2000 · DA
Modeling the effects of chronic marijuana use on neuroinflammation and HIV-related neuronal injury
$803,012Christina S Meade · Wake Forest University Health Sciences · R01 · FY2023 · DA
Does medical cannabis reduce opioid analgesics in HIV+ and HIV- adults with pain?
$802,762Chinazo Cunningham · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DA